Kwon; Byoung Se

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kwon; Byoung Se.The latest application filed is for "anticancer t cell therapy product-assisting composition comprising depleting anti-cd4 monoclonal antibody and use thereof".

Company Profile

1.12.22

Kwon; Byoung Se - Seoul KR
KWON; Byoung Se - Goyang-si KR
Kwon; Byoung Se - Gyeonggi-do KR
Kwon; Byoung Se - Ulsan KR
Kwon; Byoung Se - Carmel IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof Grant 11,396,555 - Kwon , et al. July 26, 2	2022-07-26
Anticancer T Cell Therapy Product-assisting Composition Comprising Depleting Anti-cd4 Monoclonal Antibody And Use Thereof App 20210169930 - CHOI; Beom Kyu ; et al.	2021-06-10
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof App 20190375851 - Kwon; Byoung Se ; et al.	2019-12-12
HAR-NDS-derived stem cells, method for separating same, and use thereof Grant 10,471,097 - Kwon Nov	2019-11-12
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma And Use Thereof App 20180171026 - KWON; Byoung SE ; et al.	2018-06-21
Novel Epitope For Switching To Th17 Cell And Use Thereof App 20180170997 - Kwon; Byoung Se	2018-06-21
Methods For Isolating And Proliferating Autologous Cancer Antigen-specific Cd8+ T Cells App 20180057793 - Kwon; Byoung Se ; et al.	2018-03-01
Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof Grant 9,862,775 - Kwon , et al. January 9, 2	2018-01-09
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof App 20170306043 - Kwon; Byoung Se ; et al.	2017-10-26
Har-nds-derived Stem Cells, Method For Separating Same, And Use Thereof App 20170173077 - KWON; Byoung Se	2017-06-22
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof App 20160257762 - Kwon; Byoung Se ; et al.	2016-09-08
Novel Epitope for Switching to Th17 Cell and Use Thereof App 20160244503 - Kwon; Byoung Se	2016-08-25
Monoclonal antibody specifically recognizing an epitope for switching to Th17 cell Grant 9,309,321 - Kwon April 12, 2	2016-04-12
Novel Epitope for Switching to TH2 Cell and Use Thereof App 20160046691 - Kwon; Byoung Se	2016-02-18
Antibody specifically recognizing an epitope for switching to Th2 cell and a method for converting T cell to type 2 helper T cell using the same Grant 9,255,152 - Kwon February 9, 2	2016-02-09
Antibody specifically recognizing an epitope for switching to T.sub.H1 cell Grant 9,255,151 - Kwon February 9, 2	2016-02-09
Novel Epitope for Switching to TH1 Cell and Use Thereof App 20160024177 - Kwon; Byoung Se	2016-01-28
Methods for Isolating and Proliferating Autologous Cancer AntiGen-Specific CD8+ T Cells App 20150259646 - Kwon; Byoung Se ; et al.	2015-09-17
Novel Epitope For Switching To Th17 Cell And Use Thereof App 20140072565 - KWON; Byoung Se	2014-03-13
Novel Epitope For Switching To Th2 Cell And Use Thereof App 20140072566 - KWON; Byoung Se	2014-03-13
Novel Epitope For Switching To Th1 Cell And Use Thereof App 20140065152 - KWON; Byoung Se	2014-03-06
Anti-IRC85 monoclonal antibody; and composition comprising the same for preventing and treating tuberculosis or enteritis disease; and the use thereof Grant 8,445,643 - Kwon May 21, 2	2013-05-21
Method of isolating and proliferating autologous antigen-specific CD8.sup.+ T cell using anti-4-1BB antibodies Grant 7,932,045 - Kwon April 26, 2	2011-04-26
New Anti-irc85 Monoclonal Antibody; And Composition Comprising The Same For Preventing And Treating Tuberculosis Or Enteritis Disease; And The Use Thereof App 20100291101 - Kwon; Byoung Se	2010-11-18
Composition comprising humanized antibody HBBK4 for the treatment of cancer and the use thereof Grant 7,829,088 - Kwon November 9, 2	2010-11-09
Composition Comprising Humanized Antibody HBBK4 for the Treatment of Cancer and the Use Thereof App 20090041763 - Kwon; Byoung Se	2009-02-12
Method of isolating and proliferating autologous antigen-specific CD8+ T Cell using anti-4-1BB antibodies App 20080261307 - Kwon; Byoung Se	2008-10-23
Combined Pharmaceutical Composition Comprising an Anti-4-1BB Monoclonal Antibody and Chemotherapeutic Anti-Cancer Agent for Preventing and Treating Cancer Disease App 20080008716 - KWON; Byoung Se	2008-01-10
Pharmaceutical Composition Comprising the Anti-4-1Bb Antibody for Treating or Preventing Rheumatoid Arthritis App 20070253961 - Kwon; Byoung Se	2007-11-01
Nucleic acid encoding MIP-1.alpha. Lymphokine Grant 6,355,476 - Kwon , et al. March 12, 2	2002-03-12
CDNA clones for a regulatory protein in the melanin-production pathway Grant 5,679,511 - Kwon October 21, 1	1997-10-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.